Why will there never be a randomized trial for NTRK-rearranged tumors?

Armelle Dufresne, Daniel Pissaloux, Carine Ngo, Nicolas Penel, Axel Le Cesne, Nicolas Macagno, Hélène Vanacker, Myriam Jean‐Denis, Franck Tirode, Jean Yves Blay, Mehdi Brahmi

Article

Discussion(0)

No comments yet. Be the first to comment.

Publication Info

DOI: 10.1016/j.annonc.2023.04.001
Year: 2023
Published: —
Language: en

Letter Details

Volume: 34
Issue: 7
Link Of The Paper: https://doi.org/10.1016/j.annonc.2023.04.001

Timeline

Created:June 19, 2026

2023

Natural history and treatment efficacy in an ambispective case series of NTRK-rearranged mesenchymal tumors

Armelle Dufresne, Daniel Pissaloux, Carine Ngo, Nicolas Penel, Axel Le Cesne, Nicolas Macagno, Hélène Vanacker, Clémence Hénon, Myriam Jean‐Denis, K Rughoo, Franck Tirode, Jean Yves Blay, Mehdi Brahmi

Article2005

Will it be steroids for ever?

Peter J Barnes

Chapter in a book2010

Should there be a category: “grooming disorders?”

Lara Hoppe, Jonathan Ipser, Christine Löchner, Kevin G. F. Thomas, Dan Joseph Stein

Article2019

Will the Photobiomodulation Trial Be the One to Turn the Tide Against Alzheimer Disease

Michael R Hamblin